Vimarsana
Biggest News Aggregation in the World

Page 33 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genentech Today - Breaking & Trending Today

Examining the Evolution of Treatment With CDK4/6 Inhibitors in Metastatic Breast Cancer - Vimarsana News

Examining the Evolution of Treatment With CDK4/6 Inhibitors in Metastatic Breast Cancer

Anne Favret, MD on FDA Approval of Capivasertib (Truqap) in Combination with Fulvestrant for HR-positive, HER2-negative Breast Cancer

Roche, Adaptimmune part ways on cell therapy research - Vimarsana News

Roche, Adaptimmune part ways on cell therapy research

BioPharma

The EPIC Act is the bipartisan fix North Carolina patients deserve - Vimarsana News

The EPIC Act is the bipartisan fix North Carolina patients deserve

U.S. Congressman Greg Murphy recently introduced a bill that could make an enormous difference for patients while protecting hundreds of thousands of good-paying North Carolina jobs.

Source: jdnews.com
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis - Vimarsana News

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis

The Elecsys® pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly and CompanyOnce approved, the test will aid healthcare providers in...

US sues Regeneron, alleging false price reporting on Eylea - Vimarsana News

US sues Regeneron, alleging false price reporting on Eylea

BioPharma